235 related articles for article (PubMed ID: 17410539)
1. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
Malik G; Ward MD; Gupta SK; Trosset MW; Grizzle WE; Adam BL; Diaz JI; Semmes OJ
Clin Cancer Res; 2005 Feb; 11(3):1073-85. PubMed ID: 15709174
[TBL] [Abstract][Full Text] [Related]
3. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
[TBL] [Abstract][Full Text] [Related]
4. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
7. Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.
Becker AM; Das S; Xia Z; Liu Z; Adam BL; Kountakis SE
Am J Rhinol; 2008; 22(2):139-43. PubMed ID: 18416969
[TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
McLerran D; Grizzle WE; Feng Z; Thompson IM; Bigbee WL; Cazares LH; Chan DW; Dahlgren J; Diaz J; Kagan J; Lin DW; Malik G; Oelschlager D; Partin A; Randolph TW; Sokoll L; Srivastava S; Srivastava S; Thornquist M; Troyer D; Wright GL; Zhang Z; Zhu L; Semmes OJ
Clin Chem; 2008 Jan; 54(1):53-60. PubMed ID: 18024530
[TBL] [Abstract][Full Text] [Related]
9. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
10. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Grizzle WE; Adam BL; Bigbee WL; Conrads TP; Carroll C; Feng Z; Izbicka E; Jendoubi M; Johnsey D; Kagan J; Leach RJ; McCarthy DB; Semmes OJ; Srivastava S; Srivastava S; Thompson IM; Thornquist MD; Verma M; Zhang Z; Zou Z
Dis Markers; 2003-2004; 19(4-5):185-95. PubMed ID: 15258333
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
12. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
13. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer.
Kohli M; Siegel E; Bhattacharya S; Khan MA; Shah R; Suva LJ
Cancer Biomark; 2006; 2(6):249-58. PubMed ID: 17264396
[TBL] [Abstract][Full Text] [Related]
14. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
16. [Application of SELDI-TOF MS technology analyzing serum protein profiling for distinguishing laryngeal carcinoma from ordinary people].
Zhang X; Chen Y; Wang J; Qu X; Deng B; Wang J; Xie G; Li M; Xu F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):842-6. PubMed ID: 17144495
[TBL] [Abstract][Full Text] [Related]
17. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Campylobacter species by surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry.
Kiehntopf M; Melcher F; Hänel I; Eladawy H; Tomaso H
Foodborne Pathog Dis; 2011 Aug; 8(8):875-85. PubMed ID: 21524195
[TBL] [Abstract][Full Text] [Related]
19. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
